Evidence supporting the use of: Cannabidiol
For the health condition: Nerve Damage

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Cannabidiol (CBD) is increasingly studied for its potential role in supporting or treating nerve damage, also known as neuropathy. Scientific research has explored CBD's effects on neuropathic pain, which is a common symptom of nerve damage. Preclinical studies in animal models suggest that CBD may reduce inflammation and modulate pain signaling by interacting with the endocannabinoid system, specifically the CB1 and CB2 receptors, as well as other molecular targets involved in pain pathways.

Several small-scale human studies and case reports indicate that CBD may alleviate neuropathic pain in conditions such as multiple sclerosis and diabetic neuropathy. For example, a 2020 randomized controlled trial published in Current Pharmaceutical Biotechnology found that topical CBD oil reduced pain in patients with peripheral neuropathy of the lower extremities. Other studies have investigated CBD in combination with THC (as in nabiximols/Sativex) for neuropathic pain, showing moderate benefit.

Despite these findings, the overall quality and quantity of evidence is still limited. Most studies are small, short-term, or lack rigorous controls. Systematic reviews and meta-analyses conclude that while there is promise, more large-scale, high-quality clinical trials are needed to establish efficacy and optimal dosing. Currently, CBD is not an FDA-approved treatment for nerve damage, but it remains an area of active research and off-label use for neuropathic pain relief.

More about Cannabidiol
More about Nerve Damage

Products containing Cannabidiol

We currently have no products on Vitabase that contain this ingredient.